• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜母细胞瘤蛋白介导的主动转录抑制机制。

Mechanism of active transcriptional repression by the retinoblastoma protein.

作者信息

Weintraub S J, Chow K N, Luo R X, Zhang S H, He S, Dean D C

机构信息

Department of Medicine, Washington University School of Medicine, St Louis, Missouri 63110, USA.

出版信息

Nature. 1995 Jun 29;375(6534):812-5. doi: 10.1038/375812a0.

DOI:10.1038/375812a0
PMID:7596417
Abstract

The retinoblastoma tumour-suppressor protein (Rb) belongs to a family that share a motif known as the pocket. The pocket was originally identified as the region of Rb required for binding to oncoproteins from DNA tumour viruses, which disrupt the binding of Rb to the E2F family of cell-cycle transcription factors (referred to collectively here as E2F). Rb switches E2F sites from positive to negative elements, suggesting that Rb-E2F is an active complex that blocks transcription. Here we report that Rb is selectively recruited to promoters through E2F, where it in turn inactivates surrounding transcription factors by blocking their interaction with the basal transcription complex. We suggest that this repressor activity is essential for inhibiting promoters that contain enhancers in addition to E2F sites.

摘要

视网膜母细胞瘤肿瘤抑制蛋白(Rb)属于一个共享被称为“口袋”基序的家族。该口袋最初被鉴定为Rb与DNA肿瘤病毒癌蛋白结合所需的区域,这些癌蛋白会破坏Rb与细胞周期转录因子E2F家族(此处统称为E2F)的结合。Rb将E2F位点从正调控元件转变为负调控元件,这表明Rb - E2F是一个阻止转录的活性复合物。在此,我们报告Rb通过E2F被选择性招募到启动子区域,在那里它通过阻断周围转录因子与基础转录复合物的相互作用来使其失活。我们认为这种抑制活性对于抑制除E2F位点外还含有增强子的启动子至关重要。

相似文献

1
Mechanism of active transcriptional repression by the retinoblastoma protein.视网膜母细胞瘤蛋白介导的主动转录抑制机制。
Nature. 1995 Jun 29;375(6534):812-5. doi: 10.1038/375812a0.
2
RBP1 induces growth arrest by repression of E2F-dependent transcription.视黄醇结合蛋白1通过抑制E2F依赖的转录诱导生长停滞。
Oncogene. 1999 Mar 25;18(12):2091-100. doi: 10.1038/sj.onc.1202520.
3
The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.p107肿瘤抑制因子诱导E2F与DNA稳定结合,从而抑制靶启动子。
Oncogene. 2001 Apr 5;20(15):1882-91. doi: 10.1038/sj.onc.1204278.
4
DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.DNMT1与Rb、E2F1和HDAC1形成复合物,并抑制E2F反应性启动子的转录。
Nat Genet. 2000 Jul;25(3):338-42. doi: 10.1038/77124.
5
Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.prohibitin是一种潜在的肿瘤抑制因子,它与RB相互作用并调节E2F功能。
Oncogene. 1999 Jun 10;18(23):3501-10. doi: 10.1038/sj.onc.1202684.
6
E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.人源MYC的E2F依赖性调控:细胞周期蛋白D1和A的反式激活作用超越肿瘤抑制蛋白功能。
Oncogene. 1994 Jul;9(7):2029-36.
7
Retinoblastoma protein represses transcription by recruiting a histone deacetylase.视网膜母细胞瘤蛋白通过招募组蛋白去乙酰化酶来抑制转录。
Nature. 1998 Feb 5;391(6667):601-5. doi: 10.1038/35410.
8
Dual mechanisms of repression of E2F1 activity by the retinoblastoma gene product.视网膜母细胞瘤基因产物对E2F1活性的双重抑制机制。
EMBO J. 1996 Nov 1;15(21):5917-27.
9
Retinoblastoma protein recruits histone deacetylase to repress transcription.视网膜母细胞瘤蛋白招募组蛋白去乙酰化酶以抑制转录。
Nature. 1998 Feb 5;391(6667):597-601. doi: 10.1038/35404.
10
Retinoblastoma protein switches the E2F site from positive to negative element.
Nature. 1992 Jul 16;358(6383):259-61. doi: 10.1038/358259a0.

引用本文的文献

1
Retinoblastoma protein activity revealed by CRISPRi study of divergent Rbf1 and Rbf2 paralogs.通过对不同的Rbf1和Rbf2旁系同源物进行CRISPR干扰研究揭示视网膜母细胞瘤蛋白活性
G3 (Bethesda). 2024 Oct 4;14(12). doi: 10.1093/g3journal/jkae238.
2
CDKL3 is a targetable regulator of cell cycle progression in cancers.CDKL3 是癌症中细胞周期进程的一个可靶向调节因子。
J Clin Invest. 2024 Jul 4;134(16):e178428. doi: 10.1172/JCI178428.
3
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.MYC 通过促进 pRB1 降解诱导 CDK4/6 抑制剂耐药性。
Nat Commun. 2024 Feb 29;15(1):1871. doi: 10.1038/s41467-024-45796-w.
4
Selective Occupation by E2F and RB of Loci Expressed by RNA Polymerase III.E2F和RB对RNA聚合酶III所表达基因座的选择性占据。
Cancers (Basel). 2024 Jan 23;16(3):481. doi: 10.3390/cancers16030481.
5
Combined CDK4/6 and ERK1/2 Inhibition Enhances Antitumor Activity in NF1-Associated Plexiform Neurofibroma.联合 CDK4/6 和 ERK1/2 抑制增强 NF1 相关丛状神经纤维瘤的抗肿瘤活性。
Clin Cancer Res. 2023 Sep 1;29(17):3438-3456. doi: 10.1158/1078-0432.CCR-22-2854.
6
Type 2 transglutaminase in the nucleus: the new epigenetic face of a cytoplasmic enzyme.细胞核内的 2 型转谷氨酰胺酶:细胞质酶的新表观遗传面貌。
Cell Mol Life Sci. 2023 Jan 25;80(2):52. doi: 10.1007/s00018-023-04698-8.
7
Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells.贝母素甲和石耳黄素 A 联合对神经胶质瘤干细胞的协同抗癌作用。
Molecules. 2022 Nov 17;27(22):7968. doi: 10.3390/molecules27227968.
8
Cyclins and cyclin-dependent kinases: from biology to tumorigenesis and therapeutic opportunities.细胞周期蛋白与细胞周期蛋白依赖性激酶:从生物学特性到肿瘤发生及治疗机遇
J Cancer Res Clin Oncol. 2023 Apr;149(4):1585-1606. doi: 10.1007/s00432-022-04135-6. Epub 2022 Jul 4.
9
The Inhibitors of CDK4/6 from a Library of Marine Compound Database: A Pharmacophore, ADMET, Molecular Docking and Molecular Dynamics Study.从海洋化合物数据库文库中筛选 CDK4/6 抑制剂:药效团、ADMET、分子对接和分子动力学研究。
Mar Drugs. 2022 May 12;20(5):319. doi: 10.3390/md20050319.
10
Targeting CDK4 and CDK6 in cancer.针对癌症中的 CDK4 和 CDK6。
Nat Rev Cancer. 2022 Jun;22(6):356-372. doi: 10.1038/s41568-022-00456-3. Epub 2022 Mar 18.